Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 143K 128K 119K 109K 204K 13.89M 206K 1.43M 561K 7.06M 538K 527K 22.69M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.49M 19.12M 17.37M 32.68M 2.22B 33M 230M 89.77M 1.13B 86.16M 84.29M 3.63B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.52% | -0.08% | +21.59% | +30.78% | 245B | |
| -0.47% | +2.69% | +6.10% | +0.11% | 154B | |
| +0.21% | +3.53% | -7.29% | +40.49% | 146B | |
| +1.11% | -2.75% | -56.57% | -19.34% | 60.26B | |
| -1.80% | -1.12% | +11.22% | +14.30% | 49.44B | |
| -0.78% | +1.73% | -21.18% | -19.35% | 48.04B | |
| -0.54% | +0.89% | +19.43% | +52.00% | 47.67B | |
| +0.83% | +1.03% | -5.62% | +35.90% | 45.74B | |
| -1.57% | +0.85% | +30.97% | +60.48% | 42.84B | |
| Average | -0.50% | +0.37% | -0.15% | +21.71% | 93.2B | |
| Weighted average by Cap. | -0.63% | +0.45% | +3.91% | +22.42% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.54M 1.44M 1.31M 2.46M 167M 2.49M 17.3M 6.77M 85.11M 6.49M 6.35M 274M | 1.98M 1.77M 1.65M 1.5M 2.82M 192M 2.84M 19.78M 7.74M 97.33M 7.43M 7.26M 313M |
| Net income | -16.08M -14.36M -13.39M -12.17M -22.89M -1.56B -23.12M -161M -62.89M -791M -60.36M -59.05M -2.54B | -29.31M -26.18M -24.42M -22.18M -41.74M -2.84B -42.15M -293M -115M -1.44B -110M -108M -4.64B |
| Net Debt | 20.53M 18.33M 17.1M 15.53M 29.23M 1.99B 29.51M 205M 80.3M 1.01B 77.07M 75.39M 3.25B | 22.8M 20.36M 19M 17.26M 32.47M 2.21B 32.79M 228M 89.21M 1.12B 85.62M 83.76M 3.61B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
